Total Biopharma Navigation
  • R&D
  • Drug Discovery
  • Clinical Trials
  • Manufacturing
  • Regulation & Compliance
  • Pricing & Market Access
  • Engagement & Marketing
  • Partnering & Investment
  • Orphan Drugs
  • Press Releases
  • Whitepapers
  • Advertise
AE

Tag Archive

Below you'll find a list of all posts that have been tagged as “AE”

How is the drug safety industry responding to signal detection requirements?

  How is the industry prioritising signal detection in drug safety in light of many regulatory and industry pressures? Signal detection is such a core element in a successful safety and benefit risk management strategy and one of huge importance to safety teams. A number of elements need to be working in harmony to ensure that a true representation of …

Read More
ADRAEdrug safetypharmacovigilancesignal detection

AE reporting through the Yellow Card System – how well does it work?

How is the Yellow Card System in the UK's NHS working? I started thinking about this while I was analysing results from a poll that we did at last year's World Drug Safety Congress Europe, looking at ways to improve risk communication and adverse event reporting. The poll asked the audience to rate innovative and effective systems and the yellow …

Read More
adverse eventAEUncategorizedYCSyellow card system

Our Events

  • Phar-East 2018

Sectors

Antibodies

Stem Cells

Cell Culture

Generics

Biosimilars

Oncology

Antibodies

Toggle the Widgetbar
  • Phar-East 2018